CollPlant Biotechnologies Ltd.
-
Ticker
CLGN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Rehovot, Israel
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. Their products are based on their rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology. Their products address indications for the diverse fields of tissue repair, aesthetics and organ
…More manufacturing, and, they believe, are ushering in a new era in regenerative and aesthetic medicine. Their flagship rhCollagen BioInk product line is ideal for 3D bioprinting of tissues and organs. In October 2018, they entered into a licensing agreement with United Therapeutics, whereby United Therapeutics is using CollPlant's BioInks in the manufacture of 3D bioprinted lungs for transplant in humans.
REPORT RATINGS
4.8 / 5.0 (96)
CollPlant Biotechnologies Ltd. reports have an aggregate usefulness score of 4.8 based on 96 reviews.
CollPlant Biotechnologies Ltd.
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports